Acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) is a type of respiratory failure marked by rapid onset of widespread lung inflammation. It impairs the lungs' ability to exchange oxygen and carbon dioxide, leading to symptoms such as shortness of breath, rapid breathing, and bluish skin coloration. The syndrome is notable for its high death rate, ranging from 35 to 46%, and for affecting more than 3 million people globally each year.
Quick Facts
- Field
- Critical care medicine
- Symptoms
- Shortness of breath
- rapid breathing
- bluish skin coloration
- chest pain
- loss of speech
- Complications
- Blood clots
- Collapsed lung (pneumothorax)
- Infections
- Scarring (pulmonary fibrosis)
- Onset
- Within a week
- Diagnosis
- Adults: PaO; 2, FiO; 2; ratio of less than 300 mm (1 ft) Hg; Children: oxygenation index > 4
- Differential
- Heart failure
- Treatment
- Mechanical ventilation, ECMO
- Prognosis
- 35–46% risk of death
Facts from the source article.
Did You Know?
- Signs and symptoms of ARDS often begin within two hours of an inciting event, but may take as long as 1–3 days.
- Complications can include barotrauma, pulmonary embolism, pulmonary fibrosis, ventilator-associated pneumonia, and hypoxic brain damage.
- Rates of ARDS increased in 2020 due to COVID-19, with some cases appearing similar to HAPE.
Frequently Asked Questions
How is Acute respiratory distress syndrome treated?
Treatment of Acute respiratory distress syndrome includes mechanical ventilation and ECMO.
How is Acute respiratory distress syndrome diagnosed?
Diagnosis of Acute respiratory distress syndrome is based on Adults: PaO, 2, FiO, 2, ratio of less than 300 mm (1 ft) Hg and children: oxygenation index > 4.
More in Intensive Care Medicine
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced